Shanghai, China

Zhiyong Li

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:

goldMedal1 out of 832,680 
Other
 patents

Years Active: 2019

Loading Chart...
1 patent (USPTO):

Title: Zhiyong Li: Innovator in Hypolipidemic and Hypoglycemic Solutions

Introduction

Zhiyong Li, an esteemed inventor based in Shanghai, China, has made significant contributions to the field of medicine through his innovative research. He holds a notable patent that addresses important health issues such as blood glucose and triglyceride levels.

Latest Patents

Zhiyong Li is recognized for his patent titled "Methods of reducing blood glucose or triglyceride levels by administration of METRNL protein." This invention presents a groundbreaking application of Metrnl protein in the creation of a hypolipidemic and hypoglycemic medicine or dietary supplement. In addition to this, the patent also outlines a method for producing a mouse that has fat-specific overexpression of Metrnl, an important advancement for research in metabolic diseases.

Career Highlights

Throughout his career, Zhiyong Li has demonstrated a commitment to improving health through innovative solutions. His work in the development of therapeutic approaches using Metrnl protein showcases his expertise in medical research and dedication to enhancing human health. Li's contributions continue to have a positive impact on the scientific community and the treatment of metabolic disorders.

Collaborations

Zhiyong Li has collaborated with notable coworkers Chaoyu Miao and Pei Wang. Together, these innovators work towards advancing research in metabolic health and exploring the potential of Metrnl protein in medicine. Their combined efforts reflect a strong commitment to scientific collaboration and innovation.

Conclusion

Zhiyong Li's invention and ongoing contributions in the field of medicine exemplify the power of innovation in addressing critical health challenges. Through his patent, he has opened new avenues for research and development in treating issues related to blood glucose and triglyceride levels. As he continues to work alongside talented researchers, his future endeavors promise to further enhance our understanding of metabolic health and therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…